How does MD Anderson Cancer Center choose and integrate new technology?
MD Anderson | August 01, 2017
At the MedCity CONVERGE conference this week, Rebecca Kaul, MD Anderson Cancer Center Chief Innovation Officer offered an overview on a topic familiar to other providers and often mystifying to new healthcare startups - how does it decide on which new technologies to integrate and why? Although she refrained from naming any vendors and wouldn’t go near the decision to end a collaboration with IBM Watson Health, she highlighted some of the factors that go into making these decisions.